128 related articles for article (PubMed ID: 12220003)
21. Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here?
Gordon LI
Lancet Haematol; 2018 Sep; 5(9):e381-e382. PubMed ID: 30172340
[No Abstract] [Full Text] [Related]
22. Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients.
de Mendonça GR; Brito AB; Rocha RM; Delamain MT; de Andrade Natal R; Soares FA; Colleoni GW; Souza CA; Vassallo J; Lima CS
Blood Cancer J; 2016 Aug; 6(8):e464. PubMed ID: 27564462
[No Abstract] [Full Text] [Related]
23. [A case report of severe hypo-phosphatemia due to paraneoplastic syndrome followed by severe hyper-phosphatemia due to tumor lysis syndrome after CHOP chemotherapy].
Ito T; Uchida Y; Takagi S; Uchida N; Taniguchi S; Hayashi M
Gan To Kagaku Ryoho; 2012 Feb; 39(2):325-8. PubMed ID: 22333654
[TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
Plumb R; Doolittle GC
Am J Hematol; 1996 May; 52(1):58-9. PubMed ID: 8638613
[TBL] [Abstract][Full Text] [Related]
25. [A case of follicular lymphoma complicated with lethal pemphigus].
Imataki O; Tamai Y; Abe Y; Ito I; Yoshikawa S; Kawakami K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1677-80. PubMed ID: 17108741
[TBL] [Abstract][Full Text] [Related]
26. A case of follicular lymphoma associated with paraneoplastic cerebellar degeneration.
Shimazu Y; Minakawa EN; Nishikori M; Ihara M; Hashi Y; Matsuyama H; Hishizawa M; Yoshida S; Kitano T; Kondo T; Ishikawa T; Takahashi R; Takaori-Kondo A
Intern Med; 2012; 51(11):1387-92. PubMed ID: 22687848
[TBL] [Abstract][Full Text] [Related]
27. Good response of a paraneoplastic neuromyopathy to cyclophosphamide.
Bruyland M; Van Belle S; Schallier D; Ebinger G; Martin JJ
Cancer Treat Rep; 1984 May; 68(5):787-9. PubMed ID: 6327036
[TBL] [Abstract][Full Text] [Related]
28. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
[TBL] [Abstract][Full Text] [Related]
29. Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
Griffiths R; Gleeson M; Reyes C; Knopf K; Danese M
Am J Hematol; 2010 Dec; 85(12):963-7. PubMed ID: 20981680
[No Abstract] [Full Text] [Related]
30. Subcutaneous rituximab and chemotherapy achieves similar overall response rates to intravenous rituximab in first-line follicular lymphoma: efficacy and safety results of the phase III SABRINA study.
Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):6-7. PubMed ID: 25768992
[No Abstract] [Full Text] [Related]
31. Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study.
Tilly H; Morschhauser F; Casasnovas O; Molina TJ; Feugier P; Gouill SL; Haioun C; Tournilhac O; Bouabdallah R; Gabarre J; Lamy T; Cabeçadas J; Becker S; Jardin F; Mounier N; Salles G;
Lancet Haematol; 2018 Sep; 5(9):e403-e410. PubMed ID: 30172345
[TBL] [Abstract][Full Text] [Related]
32. [Primary cutaneous follicle centre lymphoma: report of a case].
Rong YF; He LM; Zhang YS; Feng YZ
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):769-70. PubMed ID: 24447559
[No Abstract] [Full Text] [Related]
33. The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.
Rossi D; Bruscaggin A; La Cava P; Galimberti S; Ciabatti E; Luminari S; Rigacci L; Tucci A; Pulsoni A; Bertoldero G; Vallisa D; Rusconi C; Spina M; Arcaini L; Angrilli F; Stelitano C; Merli F; Gaidano G; Federico M; Palumbo GA
Haematologica; 2015 Apr; 100(4):517-24. PubMed ID: 25596266
[TBL] [Abstract][Full Text] [Related]
34. A rare case of bilateral chylothorax: a diagnostic challenge--follicular lymphoma versus primary effusion lymphoma.
Podder S; Mora M; Patel V; Sivamurthy S
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26282457
[TBL] [Abstract][Full Text] [Related]
35. A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma.
Cornish N; Maybury B; Otton S
Br J Haematol; 2018 Jan; 180(2):176. PubMed ID: 29048103
[No Abstract] [Full Text] [Related]
36. New treatment options have changed the survival of patients with follicular lymphoma.
Fisher RI; LeBlanc M; Press OW; Maloney DG; Unger JM; Miller TP
J Clin Oncol; 2005 Nov; 23(33):8447-52. PubMed ID: 16230674
[TBL] [Abstract][Full Text] [Related]
37. A skin rash and what lies beneath: paraneoplastic pemphigus, an atypical presentation of follicular cell lymphoma.
Moustafa MA; Seningen JL; Jouni H; Singh PP; el-Azhary RA; Witzig TE
Am J Hematol; 2013 Sep; 88(9):822-3. PubMed ID: 23658142
[No Abstract] [Full Text] [Related]
38. [Hodgkin's disease manifesting as paraneoplastic limbic encephalitis].
Bernard P; Vinzio S; Talarmin F; Kadouri A; Flocard F
Rev Med Interne; 2003 Apr; 24(4):257-60. PubMed ID: 12706783
[TBL] [Abstract][Full Text] [Related]
39. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
[TBL] [Abstract][Full Text] [Related]
40. Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report.
Nicolatou-Galitis O; Papadaki T; Moschovi M; Kamma JJ; van Vliet-Constantinidou C; Tsoumakas C; Kattamis A; Tzortzatou-Stathopoulou F
J Periodontol; 2001 Jan; 72(1):107-12. PubMed ID: 11210066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
